Jpmorgan Chase & CO Jazz Pharmaceuticals PLC Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,662,042 shares of JAZZ stock, worth $182 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,662,042

Previous 1,587,541 4.69%

Holding current value

$182 Million

Previous $196 Million 5.54%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$120.07 - $144.17 $8.95 Million - $10.7 Million	74,501 Added 4.69%	1,662,042 $206 Million
Q4 2024 Feb 12, 2025	BUY	$107.32 - $127.74 $7.73 Million - $9.2 Million	72,007 Added 4.75%	1,587,541 $196 Million
Q3 2024 Dec 26, 2024	SELL	$100.57 - $116.37 $2.29 Million - $2.65 Million	-22,788 Reduced 1.48%	1,515,534 $169 Million
Q3 2024 Nov 08, 2024	SELL	$100.57 - $116.37 $2.29 Million - $2.65 Million	-22,788 Reduced 1.48%	1,515,534 $169 Million
Q2 2024 Dec 26, 2024	BUY	$103.94 - $118.98 $2.37 Million - $2.71 Million	22,788 Added 1.5%	1,538,322 $164 Million
Q2 2024 Aug 12, 2024	BUY	$103.94 - $118.98 $4.55 Million - $5.21 Million	43,784 Added 2.93%	1,538,322 $164 Million
Q1 2024 Dec 26, 2024	SELL	$115.19 - $132.77 $2.42 Million - $2.79 Million	-20,996 Reduced 1.39%	1,494,538 $180 Million
Q1 2024 May 10, 2024	BUY	$115.19 - $132.77 $11.2 Million - $12.9 Million	97,254 Added 6.96%	1,494,538 $180 Million
Q4 2023 Dec 26, 2024	SELL	$114.26 - $136.0 $13.5 Million - $16.1 Million	-118,250 Reduced 7.8%	1,397,284 $172 Million
Q4 2023 Feb 12, 2024	SELL	$114.26 - $136.0 $3.29 Million - $3.91 Million	-28,757 Reduced 2.02%	1,397,284 $172 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $33.1 Million - $39.4 Million	-270,971 Reduced 15.97%	1,426,041 $185 Million
Q2 2023 Aug 11, 2023	SELL	$122.5 - $147.16 $52.8 Million - $63.4 Million	-430,992 Reduced 20.25%	1,697,012 $210 Million
Q1 2023 May 18, 2023	BUY	$133.98 - $160.47 $10.1 Million - $12.1 Million	75,616 Added 3.68%	2,128,004 $311 Million
Q1 2023 May 11, 2023	SELL	$133.98 - $160.47 $107 Million - $128 Million	-799,106 Reduced 28.02%	2,052,388 $300 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $85.5 Million - $105 Million	-659,347 Reduced 18.78%	2,851,494 $454 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $16.9 Million - $21.6 Million	133,780 Added 3.96%	3,510,841 $468 Million
Q2 2022 Aug 11, 2022	BUY	$141.59 - $168.66 $12.4 Million - $14.8 Million	87,895 Added 2.67%	3,377,061 $527 Million
Q1 2022 May 11, 2022	BUY	$129.64 - $160.7 $8.73 Million - $10.8 Million	67,374 Added 2.09%	3,289,166 $512 Million
Q4 2021 Feb 10, 2022	BUY	$119.87 - $145.67 $39 Million - $47.4 Million	325,479 Added 11.24%	3,221,792 $410 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $373 Million - $535 Million	2,896,313 New	2,896,313 $377 Million

Others Institutions Holding JAZZ

# of Institutions

600

Shares Held

60.6M

Call Options Held

424K

Put Options Held

190K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.86B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Jazz Pharmaceuticals PLC Transaction History